Business Context and Reporting Period
Company: Duos Technologies Group, Inc. (DUOT)
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2026
Reporting Period: The filing covers the pricing of a public offering on February 26, 2026, and the closing of the offering on March 2, 2026.
Key Financial Metrics
This filing details a capital raise event rather than operational financial performance. Key metrics include:
- Gross Proceeds: Approximately $65 million.
- Shares Sold: 8,666,666 shares of Common Stock.
- Public Offering Price: $7.50 per share.
- Underwriter's Option: 30-day option to purchase up to 1,299,999 additional shares at $7.50 per share.
- Warrants Issued: Warrants to purchase up to 433,334 shares (5% of shares sold) at an exercise price of $9.00 per share, exercisable for five years.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transaction report, not a periodic financial statement.
Material Changes
The primary material change is the entry into a definitive underwriting agreement with Titan Partners Group LLC (a division of American Capital Partners, LLC) to raise capital. This represents a significant increase in the company's equity capital and share count compared to the pre-offering period.
Guidance, Outlook, and Risks
Management Commentary: The Company utilized an effective shelf registration statement (File No. 333-293372) filed on February 11, 2026, to execute this offering. The proceeds are intended to support the Company's operations, though specific allocation details are not provided in this summary text.
Risks and Contingencies:
- Dilution: The issuance of new shares and warrants will dilute existing shareholders.
- Market Risk: The success of the offering is subject to market conditions, though the offering has been priced and closed.
- Underwriter Option: The potential exercise of the 30-day option could further increase the share count.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and commissions.
- Confirm the status of the Underwriter's Option (whether it was exercised within the 30-day window).
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification terms.
- Check the impact of the new share issuance on earnings per share (EPS) and ownership percentages.
- Examine the press releases (Exhibits 99.1 and 99.2) for management's stated use of proceeds.